SANUWAVE Health, Inc. Common Stock (SNWV) is a publicly traded Healthcare sector company. As of May 21, 2026, SNWV trades at $16.75 with a market cap of $144.98M and a P/E ratio of 12.18. SNWV moved +0.78% today. Year to date, SNWV is -42.62%; over the trailing twelve months it is -44.33%. Its 52-week range spans $5.63 to $46.59. Analyst consensus is buy with an average price target of $51.00. Rallies surfaces SNWV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
SANUWAVE Health Posts Record Q1 2026 Revenue Despite Market Headwinds: SANUWAVE Health delivered its highest quarterly revenue ever in Q1 2026 while management highlighted persistent market headwinds. Demand for its acoustic wave therapy devices remained robust, offsetting industry challenges that constrained margin expansion.
| Metric | Value |
|---|---|
| Price | $16.75 |
| Market Cap | $144.98M |
| P/E Ratio | 12.18 |
| EPS | $1.38 |
| Dividend Yield | 0.00% |
| 52-Week High | $46.59 |
| 52-Week Low | $5.63 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $44.05M |
| Net Income | $11.81M |
| Gross Margin | 77.11% |
2 analysts cover SNWV: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $51.00.